GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Diasorin SpA (LTS:0GZX) » Definitions » Price-to-Owner-Earnings

Diasorin SpA (LTS:0GZX) Price-to-Owner-Earnings : (As of Jun. 08, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Diasorin SpA Price-to-Owner-Earnings?

As of today (2024-06-08), Diasorin SpA's share price is €101.085. Diasorin SpA does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for Diasorin SpA's Price-to-Owner-Earnings or its related term are showing as below:

During the past 13 years, the highest Price-to-Owner-Earnings of Diasorin SpA was 48.36. The lowest was 11.90. And the median was 35.77.


LTS:0GZX's Price-to-Owner-Earnings is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 24.845
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-06-08), Diasorin SpA's share price is €101.085. Diasorin SpA's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was €3.07. Therefore, Diasorin SpA's PE Ratio for today is 32.88.

As of today (2024-06-08), Diasorin SpA's share price is €101.085. Diasorin SpA's EPS without NRI for the trailing twelve months (TTM) ended in was €3.31. Therefore, Diasorin SpA's PE Ratio without NRI for today is 30.59.

During the past 13 years, Diasorin SpA's highest PE Ratio without NRI was 62.94. The lowest was 18.30. And the median was 27.10.


Diasorin SpA Price-to-Owner-Earnings Historical Data

The historical data trend for Diasorin SpA's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diasorin SpA Price-to-Owner-Earnings Chart

Diasorin SpA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Diasorin SpA Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Diasorin SpA's Price-to-Owner-Earnings

For the Diagnostics & Research subindustry, Diasorin SpA's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Diasorin SpA's Price-to-Owner-Earnings Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Diasorin SpA's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Diasorin SpA's Price-to-Owner-Earnings falls into.



Diasorin SpA Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Diasorin SpA's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=101.085/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Diasorin SpA  (LTS:0GZX) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Diasorin SpA Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Diasorin SpA's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Diasorin SpA (LTS:0GZX) Business Description

Traded in Other Exchanges
Address
Via Crescentino Snc, Saluggia, Vercelli, ITA, 13040
Diasorin SpA is a biotechnology company engaged in developing, producing, and marketing reagent kits for laboratory diagnostics around the world. The business has focused on the immunodiagnostic market, molecular diagnostics, and Life Science sector. The company has a presence in Italy, Europe, North America, and the Rest of the world, where the majority of its revenue is from North America followed by Italy.

Diasorin SpA (LTS:0GZX) Headlines

No Headlines